RB1 and neoplasm: Hence, RB-M was administered intratumorally via ultrasound guidance injection, resulting in sufficient accumulation of RB signals within the tumor after 2 h, minimal retention at 24 h, and almost complete clearance by 48 h (Fig. S4).